Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 28, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc.
| 3.37K |
—
|
—
| +21.71% | 18.87K |
Mar 28
| |||||||
Aprea Therapeutics, Inc.
| 1.01K |
$7.29 | $7,362.90 | +6.97% | 15.5K |
Mar 13
| |||||||
Aprea Therapeutics, Inc.
| 1K |
$5.25 | $5,250.00 | +7.41% | 14.49K |
Feb 27
| |||||||
Aprea Therapeutics, Inc.
| 269.88K |
—
|
—
|
∞
| 269.88K |
Jan 30
| |||||||
Aprea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Windtree Therapeutics Inc /de/
| 3K |
$0.37 | $1,099.80 | +4.30% | 72.8K |
Jul 26
| |||||||
Windtree Therapeutics Inc /de/
| 66.3K |
—
|
—
| +1,894.29% | 69.8K |
Mar 4
| |||||||
Windtree Therapeutics Inc /de/
| 1K |
$2.07 | $2,066.90 | +40.00% | 3.5K |
Apr 16
| |||||||
Windtree Therapeutics Inc /de/
| 1.5K |
$3.25 | $4,875.00 | +150.00% | 2.5K |
Mar 25
| |||||||
Windtree Therapeutics Inc /de/
|
0
|
—
|
—
|
—
|
0
|
Jan 22
| |||||||
Windtree Therapeutics Inc /de/
| 1K |
$5.27 | $5,270.00 |
∞
| 1K |
Oct 7
| |||||||
Windtree Therapeutics Inc /de/
|
0
|
—
|
—
|
—
|
0
|
Jul 20
| |||||||
Windtree Therapeutics Inc /de/
|
0
|
—
|
—
|
—
|
0
| ||||||||
Trevena Inc
| 1.98K |
$1.17 | $2,246.28 | +2.47% | 82.23K |
May 31 - Jun 3
| |||||||
Trevena Inc
| 80K |
—
|
—
| +32,000.00% | 80.25K |
Dec 6
| |||||||
Trevena Inc
|
0
|
—
|
—
|
—
|
0
|
Aug 31
| |||||||
Trevena Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Cellectar Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||